» Articles » PMID: 21646303

Deep Brain Stimulation: Current and Future Clinical Applications

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 2011 Jun 8
PMID 21646303
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Deep brain stimulation (DBS) has developed during the past 20 years as a remarkable treatment option for several different disorders. Advances in technology and surgical techniques have essentially replaced ablative procedures for most of these conditions. Stimulation of the ventralis intermedius nucleus of the thalamus has clearly been shown to markedly improve tremor control in patients with essential tremor and tremor related to Parkinson disease. Symptoms of bradykinesia, tremor, gait disturbance, and rigidity can be significantly improved in patients with Parkinson disease. Because of these improvements, a decrease in medication can be instrumental in reducing the disabling features of dyskinesias in such patients. Primary dystonia has been shown to respond well to DBS of the globus pallidus internus. The success of these procedures has led to application of these techniques to multiple other debilitating conditions such as neuropsychiatric disorders, intractable pain, epilepsy, camptocormia, headache, restless legs syndrome, and Alzheimer disease. The literature analysis was performed using a MEDLINE search from 1980 through 2010 with the term deep brain stimulation, and several double-blind and larger case series were chosen for inclusion in this review. The exact mechanism of DBS is not fully understood. This review summarizes many of the current and potential future clinical applications of this technology.

Citing Articles

Chronic Pain and Obsessive-Compulsive Disorder: A Scoping Review.

Sloley C, Bell C, Shipton E, Williman J, Jarvis J Pain Ther. 2025; .

PMID: 39903371 DOI: 10.1007/s40122-024-00704-4.


Soft, Multifunctional MXene-Coated Fiber Microelectrodes for Biointerfacing.

Bi L, Garg R, Noriega N, Wang R, Kim H, Vorotilo K ACS Nano. 2024; 18(34):23217-23231.

PMID: 39141004 PMC: 11363215. DOI: 10.1021/acsnano.4c05797.


The influence of prior awareness on views about psychiatric electroceutical interventions among non-clinician stakeholders.

Tyron J, Bluhm R, Achtyes E, McCright A, Cabrera L Npj Ment Health Res. 2024; 2(1):6.

PMID: 38609645 PMC: 10955864. DOI: 10.1038/s44184-023-00028-9.


Liquid Crystal Polymer-Based Miniaturized Fully Implantable Deep Brain Stimulator.

Ahn S, Koh C, Park M, Jun S, Chang J, Kim S Polymers (Basel). 2023; 15(22).

PMID: 38006163 PMC: 10675735. DOI: 10.3390/polym15224439.


Current state of the art and future directions for implantable sensors in medical technology: Clinical needs and engineering challenges.

Yogev D, Goldberg T, Arami A, Tejman-Yarden S, Winkler T, Maoz B APL Bioeng. 2023; 7(3):031506.

PMID: 37781727 PMC: 10539032. DOI: 10.1063/5.0152290.


References
1.
Micheli F, Cersosimo M, Piedimonte F . Camptocormia in a patient with Parkinson disease: beneficial effects of pallidal deep brain stimulation. Case report. J Neurosurg. 2005; 103(6):1081-3. DOI: 10.3171/jns.2005.103.6.1081. View

2.
Schuurman P, Bosch D, Bossuyt P, Bonsel G, van Someren E, de Bie R . A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000; 342(7):461-8. DOI: 10.1056/NEJM200002173420703. View

3.
Velasco F, Velasco M, Velasco A, Menez D, Rocha L . Electrical stimulation for epilepsy: stimulation of hippocampal foci. Stereotact Funct Neurosurg. 2002; 77(1-4):223-7. DOI: 10.1159/000064610. View

4.
Leone M, Franzini A, Bussone G . Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med. 2002; 345(19):1428-9. DOI: 10.1056/NEJM200111083451915. View

5.
Lyons M, Birch B, Hillman R, Boucher O, Evidente V . Long-term follow-up of deep brain stimulation for Meige syndrome. Neurosurg Focus. 2010; 29(2):E5. DOI: 10.3171/2010.4.FOCUS1067. View